Aaron A. Phillips, Aasta P. Gandhi, Nicolas Hankov, Sergio D. Hernandez-Charpak, Julien Rimok, Anthony V. Incognito, Anouk E. J. Nijland, Marina D’Ercole, Anne Watrin, Maxime Berney, Aikaterini Damianaki, Grégory Dumont, Nicolò Macellari, Laura De Herde, Nadine Intering, Donovan Smith, Ryan Miller, Meagan N. Smith, Jordan Lee, Edeny Baaklini, Jean-Baptiste Ledoux, Javier G. Ordonnez, Taylor Newton, Ettore Flavio Meliadò, Léa Duguet, Charlotte Jacquet, Léa Bole-Feysot, Markus Rieger, Kristen Gelenitis, Yoann Dumeny, Miroslav Caban, Damien Ganty, Edoardo Paoles, Thomas Baumgartner, Clinical Study Team, Onward Team, Cathal Harte, Charles David Sasportes, Paul Romo, Tristan Vouga, Jemina Fasola, Jimmy Ravier, Matthieu Gautier, Frédéric Merlos, Rik Buschman, Tomislav Milekovic, Andreas Rowald, Stefano Mandija, Cornelis A. T. van den Berg, Niels Kuster, Esra Neufeld, Etienne Pralong, Lorenz Hirt, Stefano Carda, Fabio Becce, Etienne Aleton, Kyle Rogan, Patrick Schoettker, Grégoire Wuerzner, Nelleke Langerak, Noël L. W. Keijsers, Brian K. Kwon, James D. Guest, Erika Ross, John Murphy, Erkan Kurt, Steve Casha, Fady Girgis, Ilse van Nes, Kelly A. Larkin-Kaiser, Robin Demesmaeker, Léonie Asboth, Jordan W. Squair, Jocelyne Bloch, Grégoire Courtine
{"title":"恢复脊髓损伤后血流动力学稳定性的植入式系统。","authors":"Aaron A. Phillips, Aasta P. Gandhi, Nicolas Hankov, Sergio D. Hernandez-Charpak, Julien Rimok, Anthony V. Incognito, Anouk E. J. Nijland, Marina D’Ercole, Anne Watrin, Maxime Berney, Aikaterini Damianaki, Grégory Dumont, Nicolò Macellari, Laura De Herde, Nadine Intering, Donovan Smith, Ryan Miller, Meagan N. Smith, Jordan Lee, Edeny Baaklini, Jean-Baptiste Ledoux, Javier G. Ordonnez, Taylor Newton, Ettore Flavio Meliadò, Léa Duguet, Charlotte Jacquet, Léa Bole-Feysot, Markus Rieger, Kristen Gelenitis, Yoann Dumeny, Miroslav Caban, Damien Ganty, Edoardo Paoles, Thomas Baumgartner, Clinical Study Team, Onward Team, Cathal Harte, Charles David Sasportes, Paul Romo, Tristan Vouga, Jemina Fasola, Jimmy Ravier, Matthieu Gautier, Frédéric Merlos, Rik Buschman, Tomislav Milekovic, Andreas Rowald, Stefano Mandija, Cornelis A. T. van den Berg, Niels Kuster, Esra Neufeld, Etienne Pralong, Lorenz Hirt, Stefano Carda, Fabio Becce, Etienne Aleton, Kyle Rogan, Patrick Schoettker, Grégoire Wuerzner, Nelleke Langerak, Noël L. W. Keijsers, Brian K. Kwon, James D. Guest, Erika Ross, John Murphy, Erkan Kurt, Steve Casha, Fady Girgis, Ilse van Nes, Kelly A. Larkin-Kaiser, Robin Demesmaeker, Léonie Asboth, Jordan W. Squair, Jocelyne Bloch, Grégoire Courtine","doi":"10.1038/s41591-025-03614-w","DOIUrl":null,"url":null,"abstract":"A spinal cord injury (SCI) causes immediate and sustained hemodynamic instability that threatens neurological recovery and impacts quality of life. Here we establish the clinical burden of chronic hypotensive complications due to SCI in 1,479 participants and expose the ineffective treatment of these complications with conservative measures. To address this clinical burden, we developed a purpose-built implantable system based on biomimetic epidural electrical stimulation (EES) of the spinal cord that immediately triggered robust pressor responses. The system durably reduced the severity of hypotensive complications in people with SCI, removed the necessity for conservative treatments, improved quality of life and enabled superior engagement in activities of daily living. Central to the development of this therapy was the head-to-head demonstration in the same participants that EES must target the last three thoracic segments, and not the lumbosacral segments, to achieve the safe and effective regulation of blood pressure in people with SCI. These findings in 14 participants establish the path to designing a pivotal device trial that will evaluate the safety and efficacy of EES to treat the underappreciated, treatment-resistant hypotensive complications due to SCI. A purpose-built implantable system based on biomimetic epidural electrical stimulation of the spinal cord reduces the severity of hypotensive complications in people with spinal cord injury and improves quality of life.","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"31 9","pages":"2946-2957"},"PeriodicalIF":50.0000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12443590/pdf/","citationCount":"0","resultStr":"{\"title\":\"An implantable system to restore hemodynamic stability after spinal cord injury\",\"authors\":\"Aaron A. Phillips, Aasta P. Gandhi, Nicolas Hankov, Sergio D. Hernandez-Charpak, Julien Rimok, Anthony V. Incognito, Anouk E. J. Nijland, Marina D’Ercole, Anne Watrin, Maxime Berney, Aikaterini Damianaki, Grégory Dumont, Nicolò Macellari, Laura De Herde, Nadine Intering, Donovan Smith, Ryan Miller, Meagan N. Smith, Jordan Lee, Edeny Baaklini, Jean-Baptiste Ledoux, Javier G. Ordonnez, Taylor Newton, Ettore Flavio Meliadò, Léa Duguet, Charlotte Jacquet, Léa Bole-Feysot, Markus Rieger, Kristen Gelenitis, Yoann Dumeny, Miroslav Caban, Damien Ganty, Edoardo Paoles, Thomas Baumgartner, Clinical Study Team, Onward Team, Cathal Harte, Charles David Sasportes, Paul Romo, Tristan Vouga, Jemina Fasola, Jimmy Ravier, Matthieu Gautier, Frédéric Merlos, Rik Buschman, Tomislav Milekovic, Andreas Rowald, Stefano Mandija, Cornelis A. T. van den Berg, Niels Kuster, Esra Neufeld, Etienne Pralong, Lorenz Hirt, Stefano Carda, Fabio Becce, Etienne Aleton, Kyle Rogan, Patrick Schoettker, Grégoire Wuerzner, Nelleke Langerak, Noël L. W. Keijsers, Brian K. Kwon, James D. Guest, Erika Ross, John Murphy, Erkan Kurt, Steve Casha, Fady Girgis, Ilse van Nes, Kelly A. Larkin-Kaiser, Robin Demesmaeker, Léonie Asboth, Jordan W. Squair, Jocelyne Bloch, Grégoire Courtine\",\"doi\":\"10.1038/s41591-025-03614-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A spinal cord injury (SCI) causes immediate and sustained hemodynamic instability that threatens neurological recovery and impacts quality of life. Here we establish the clinical burden of chronic hypotensive complications due to SCI in 1,479 participants and expose the ineffective treatment of these complications with conservative measures. To address this clinical burden, we developed a purpose-built implantable system based on biomimetic epidural electrical stimulation (EES) of the spinal cord that immediately triggered robust pressor responses. The system durably reduced the severity of hypotensive complications in people with SCI, removed the necessity for conservative treatments, improved quality of life and enabled superior engagement in activities of daily living. Central to the development of this therapy was the head-to-head demonstration in the same participants that EES must target the last three thoracic segments, and not the lumbosacral segments, to achieve the safe and effective regulation of blood pressure in people with SCI. These findings in 14 participants establish the path to designing a pivotal device trial that will evaluate the safety and efficacy of EES to treat the underappreciated, treatment-resistant hypotensive complications due to SCI. A purpose-built implantable system based on biomimetic epidural electrical stimulation of the spinal cord reduces the severity of hypotensive complications in people with spinal cord injury and improves quality of life.\",\"PeriodicalId\":19037,\"journal\":{\"name\":\"Nature Medicine\",\"volume\":\"31 9\",\"pages\":\"2946-2957\"},\"PeriodicalIF\":50.0000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12443590/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/s41591-025-03614-w\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41591-025-03614-w","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
An implantable system to restore hemodynamic stability after spinal cord injury
A spinal cord injury (SCI) causes immediate and sustained hemodynamic instability that threatens neurological recovery and impacts quality of life. Here we establish the clinical burden of chronic hypotensive complications due to SCI in 1,479 participants and expose the ineffective treatment of these complications with conservative measures. To address this clinical burden, we developed a purpose-built implantable system based on biomimetic epidural electrical stimulation (EES) of the spinal cord that immediately triggered robust pressor responses. The system durably reduced the severity of hypotensive complications in people with SCI, removed the necessity for conservative treatments, improved quality of life and enabled superior engagement in activities of daily living. Central to the development of this therapy was the head-to-head demonstration in the same participants that EES must target the last three thoracic segments, and not the lumbosacral segments, to achieve the safe and effective regulation of blood pressure in people with SCI. These findings in 14 participants establish the path to designing a pivotal device trial that will evaluate the safety and efficacy of EES to treat the underappreciated, treatment-resistant hypotensive complications due to SCI. A purpose-built implantable system based on biomimetic epidural electrical stimulation of the spinal cord reduces the severity of hypotensive complications in people with spinal cord injury and improves quality of life.
期刊介绍:
Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors.
Nature Medicine consider all types of clinical research, including:
-Case-reports and small case series
-Clinical trials, whether phase 1, 2, 3 or 4
-Observational studies
-Meta-analyses
-Biomarker studies
-Public and global health studies
Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.